ProQR Therapeutics NV (NASDAQ:PRQR)

Delayed Data
As of 3:57pm ET
 -0.008 / -0.97%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 1.23, with a high estimate of 3.94 and a low estimate of 0.78. The median estimate represents a +50.78% increase from the last price of 0.82.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in ProQR Therapeutics NV. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.05%
Growthannually 14.48%


Growthquarterly -18.15%
Growthannually 191.51%
Key to the earnings and sales forecast charts.